Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (469)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
22
2023
382
3.000
 Why?
Anus Neoplasms
10
2023
25
2.040
 Why?
Stroke
8
2024
514
1.860
 Why?
Acquired Immunodeficiency Syndrome
11
2022
54
1.530
 Why?
Prostatic Hyperplasia
10
2015
37
1.390
 Why?
Brain
10
2024
1311
1.360
 Why?
Parkinson Disease
2
2023
155
1.200
 Why?
Randomized Controlled Trials as Topic
8
2024
608
1.170
 Why?
Chlamydia Infections
8
2017
75
1.160
 Why?
Papillomavirus Infections
6
2022
171
1.110
 Why?
Mesenchymal Stem Cell Transplantation
2
2024
23
1.040
 Why?
Sarcoma, Kaposi
12
2022
76
1.010
 Why?
Chlamydia trachomatis
6
2017
29
0.970
 Why?
Lymphoma, AIDS-Related
10
2020
16
0.940
 Why?
Brain Ischemia
2
2023
161
0.870
 Why?
Plant Extracts
5
2013
194
0.860
 Why?
Humans
103
2025
52114
0.840
 Why?
Serenoa
5
2013
7
0.820
 Why?
Rural Population
4
2023
571
0.760
 Why?
Phytotherapy
3
2012
45
0.760
 Why?
Umbilical Cord
2
2020
36
0.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1020
0.690
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.690
 Why?
Middle Aged
50
2021
13028
0.680
 Why?
Research Design
5
2022
367
0.650
 Why?
Neonatal Abstinence Syndrome
3
2024
26
0.630
 Why?
Adult
50
2022
14095
0.620
 Why?
Male
59
2024
26652
0.620
 Why?
Fetal Blood
2
2019
79
0.620
 Why?
Inflammation
3
2021
641
0.590
 Why?
Rats
9
2024
3146
0.570
 Why?
Patient Participation
1
2018
68
0.560
 Why?
Vaginosis, Bacterial
2
2015
8
0.530
 Why?
Neoplasms
3
2023
1288
0.500
 Why?
Decision Making
1
2018
277
0.500
 Why?
Antineoplastic Agents
10
2023
1214
0.490
 Why?
Mammography
1
2016
97
0.490
 Why?
Stem Cells
3
2025
182
0.480
 Why?
Female
47
2024
28055
0.480
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
47
0.460
 Why?
Aged
28
2020
10142
0.460
 Why?
Infarction, Middle Cerebral Artery
3
2024
40
0.450
 Why?
Population Density
1
2014
16
0.440
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.440
 Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.440
 Why?
Stem Cell Transplantation
4
2025
186
0.440
 Why?
Carcinoma in Situ
3
2013
72
0.430
 Why?
Cytokines
5
2023
621
0.420
 Why?
Animals
14
2025
13332
0.420
 Why?
Anti-Bacterial Agents
5
2020
796
0.410
 Why?
Uterine Cervicitis
1
2013
3
0.410
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.400
 Why?
Urethritis
2
2012
5
0.400
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
105
0.380
 Why?
Finasteride
4
2015
4
0.380
 Why?
Research Subjects
1
2013
53
0.380
 Why?
Guideline Adherence
1
2013
141
0.380
 Why?
Breast Neoplasms
3
2017
1199
0.380
 Why?
Rats, Sprague-Dawley
5
2024
1534
0.370
 Why?
Subarachnoid Hemorrhage
1
2012
58
0.370
 Why?
Patient Dropouts
1
2012
51
0.360
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
166
0.360
 Why?
Urologic Diseases
1
2011
9
0.350
 Why?
Homosexuality, Male
4
2022
52
0.350
 Why?
HIV-1
6
2020
59
0.350
 Why?
Analgesics, Opioid
4
2024
587
0.340
 Why?
Lung Neoplasms
2
2013
624
0.340
 Why?
Disease Models, Animal
5
2024
1467
0.330
 Why?
Young Adult
17
2019
4307
0.330
 Why?
United States
10
2023
5168
0.320
 Why?
Papillomaviridae
3
2019
104
0.320
 Why?
Patient Selection
1
2011
265
0.310
 Why?
Quality of Life
6
2024
878
0.310
 Why?
Lymphedema
2
2022
48
0.310
 Why?
HIV Seropositivity
3
2021
28
0.310
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.300
 Why?
Intestinal Mucosa
2
2021
222
0.300
 Why?
Asthma
2
2024
314
0.300
 Why?
Polymorphism, Single Nucleotide
3
2017
504
0.290
 Why?
Gonorrhea
2
2020
9
0.280
 Why?
Azithromycin
4
2020
25
0.280
 Why?
Uterine Cervical Neoplasms
2
2022
299
0.280
 Why?
Anal Canal
4
2023
27
0.270
 Why?
Risk Factors
8
2022
3922
0.260
 Why?
Prospective Studies
12
2022
2424
0.260
 Why?
Th1 Cells
2
2017
52
0.260
 Why?
Vascular Endothelial Growth Factor A
4
2017
187
0.250
 Why?
Mycoplasma genitalium
2
2018
2
0.240
 Why?
Prevalence
7
2021
1013
0.240
 Why?
Doxazosin
3
2015
3
0.240
 Why?
Treatment Outcome
16
2020
5456
0.240
 Why?
Mycoplasma Infections
2
2018
7
0.240
 Why?
Doxycycline
3
2015
33
0.240
 Why?
Cyclophosphamide
9
2021
173
0.240
 Why?
Cancer Vaccines
1
2006
78
0.230
 Why?
Anti-Infective Agents
2
2020
106
0.230
 Why?
Adolescent
13
2022
6681
0.230
 Why?
Vincristine
8
2021
88
0.230
 Why?
Multicenter Studies as Topic
4
2024
112
0.230
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
597
0.220
 Why?
Circadian Rhythm
1
2025
90
0.220
 Why?
Air Filters
1
2024
1
0.220
 Why?
Double-Blind Method
4
2013
718
0.210
 Why?
CD4 Lymphocyte Count
7
2020
33
0.210
 Why?
Bronchiolitis
1
2024
28
0.210
 Why?
Air Pollution, Indoor
1
2024
27
0.210
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.210
 Why?
Hyperbaric Oxygenation
1
2023
15
0.210
 Why?
Cell Differentiation
3
2025
670
0.210
 Why?
Neoplasm Staging
5
2022
766
0.210
 Why?
Substantia Nigra
1
2023
14
0.210
 Why?
alpha-Synuclein
1
2023
9
0.200
 Why?
Doxorubicin
8
2021
242
0.200
 Why?
Cisplatin
3
2022
284
0.200
 Why?
Transplantation Conditioning
2
2018
92
0.200
 Why?
Tumor Necrosis Factor-alpha
2
2017
392
0.200
 Why?
Informatics
1
2023
8
0.200
 Why?
Herpesvirus 8, Human
5
2020
97
0.200
 Why?
Prednisone
7
2021
102
0.200
 Why?
Cross-Sectional Studies
3
2021
1665
0.190
 Why?
Follow-Up Studies
8
2019
2282
0.190
 Why?
Astrocytes
1
2024
136
0.190
 Why?
Brachytherapy
1
2022
51
0.190
 Why?
Neuroprotective Agents
2
2020
101
0.190
 Why?
Watchful Waiting
1
2022
28
0.190
 Why?
Oxidative Phosphorylation
1
2022
45
0.190
 Why?
Feasibility Studies
2
2021
399
0.190
 Why?
Medical Records
1
2022
86
0.190
 Why?
Absorptiometry, Photon
1
2003
159
0.190
 Why?
Substance Withdrawal Syndrome
1
2023
166
0.190
 Why?
Brain Injuries
1
2023
158
0.190
 Why?
Vitamin D Deficiency
1
2022
46
0.180
 Why?
Viral Load
6
2020
80
0.180
 Why?
Vaccines
1
2022
49
0.180
 Why?
Child
7
2024
7147
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Clinical Trials as Topic
5
2020
463
0.180
 Why?
Case-Control Studies
3
2014
1193
0.180
 Why?
Precancerous Conditions
1
2022
85
0.180
 Why?
Lymphocyte Activation
3
2017
160
0.180
 Why?
Mouth Diseases
1
2021
5
0.180
 Why?
Vaccination
3
2022
296
0.180
 Why?
Mass Screening
2
2015
356
0.180
 Why?
Thymus Gland
1
2021
41
0.180
 Why?
Primary Health Care
2
2022
376
0.170
 Why?
Pluripotent Stem Cells
1
2021
8
0.170
 Why?
Progestins
1
2020
11
0.170
 Why?
Physical Conditioning, Animal
1
2021
62
0.170
 Why?
T-Lymphocyte Subsets
2
2017
40
0.170
 Why?
Drug Therapy, Combination
5
2015
399
0.170
 Why?
Papillomavirus Vaccines
2
2013
69
0.170
 Why?
Vagina
2
2018
46
0.170
 Why?
Etoposide
5
2021
71
0.170
 Why?
Spleen
1
2021
169
0.170
 Why?
Enzyme Inhibitors
2
2016
371
0.170
 Why?
Anti-HIV Agents
3
2020
45
0.170
 Why?
Cross-Over Studies
1
2021
238
0.170
 Why?
Genes, myc
1
2020
39
0.160
 Why?
Gene Frequency
2
2017
98
0.160
 Why?
Overweight
1
2022
230
0.160
 Why?
Transplantation, Autologous
3
2018
480
0.160
 Why?
Aged, 80 and over
5
2013
3382
0.160
 Why?
Nervous System Diseases
1
2020
94
0.160
 Why?
Dihydroxyphenylalanine
1
2019
5
0.160
 Why?
Dopaminergic Neurons
1
2019
19
0.150
 Why?
Ablation Techniques
1
2019
19
0.150
 Why?
Infant, Newborn
5
2024
2859
0.150
 Why?
Genitalia, Male
1
2019
14
0.150
 Why?
Altruism
1
2018
12
0.150
 Why?
Sodium, Dietary
1
2019
24
0.150
 Why?
Central Nervous System Diseases
1
2019
26
0.150
 Why?
Mouth
1
2019
33
0.150
 Why?
Asymptomatic Infections
1
2018
5
0.150
 Why?
Mitochondria
2
2020
421
0.150
 Why?
Dopamine
1
2019
169
0.140
 Why?
Antiviral Agents
2
2013
177
0.140
 Why?
Sexually Transmitted Diseases
1
2018
36
0.140
 Why?
Encephalitis
1
2018
39
0.140
 Why?
Hyperthermia, Induced
1
2019
114
0.140
 Why?
Chlamydia
1
2017
8
0.140
 Why?
Energy Metabolism
1
2020
312
0.140
 Why?
Mucous Membrane
1
2017
31
0.140
 Why?
Regeneration
1
2018
80
0.140
 Why?
Pilot Projects
3
2019
712
0.140
 Why?
Protein Kinase Inhibitors
2
2023
225
0.140
 Why?
Exosomes
1
2018
56
0.140
 Why?
Blood Cells
1
2017
37
0.140
 Why?
Biopsy
2
2022
599
0.140
 Why?
Genetic Predisposition to Disease
2
2018
528
0.140
 Why?
DNA, Circular
1
2017
17
0.130
 Why?
Clostridium Infections
1
2018
54
0.130
 Why?
Antibodies, Bacterial
1
2017
30
0.130
 Why?
Clonal Evolution
1
2017
59
0.130
 Why?
Immunoglobulins
1
2017
76
0.130
 Why?
Immunoglobulin G
1
2017
195
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
2
2017
234
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.120
 Why?
Anus Diseases
1
2016
2
0.120
 Why?
Telemedicine
1
2022
492
0.120
 Why?
Lymph Node Excision
1
2017
133
0.120
 Why?
Mannitol
1
2016
15
0.120
 Why?
Guidelines as Topic
1
2016
111
0.120
 Why?
Thiazoles
1
2016
52
0.120
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.120
 Why?
Diagnostic Self Evaluation
1
2015
14
0.120
 Why?
Blood-Brain Barrier
1
2016
49
0.120
 Why?
CD4-Positive T-Lymphocytes
1
2017
163
0.120
 Why?
T-Lymphocytes
1
2017
316
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1368
0.120
 Why?
Educational Status
1
2016
227
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Time Factors
6
2023
2970
0.120
 Why?
Imidazoles
1
2016
123
0.120
 Why?
Burkitt Lymphoma
1
2015
27
0.120
 Why?
Lymph Nodes
1
2017
252
0.120
 Why?
Drug Administration Schedule
5
2020
374
0.120
 Why?
Menarche
1
2014
7
0.110
 Why?
Data Collection
3
2023
286
0.110
 Why?
Stomatitis
1
2014
16
0.110
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.110
 Why?
Obesity
3
2022
1183
0.110
 Why?
Immunophenotyping
2
2017
117
0.110
 Why?
Disease-Free Survival
5
2016
462
0.110
 Why?
Hypogonadism
1
2013
12
0.100
 Why?
Benzamides
1
2013
50
0.100
 Why?
Carcinoma, Squamous Cell
1
2016
330
0.100
 Why?
Incidence
4
2018
1070
0.100
 Why?
Health Surveys
1
2014
238
0.100
 Why?
Urban Population
1
2014
161
0.100
 Why?
SEER Program
1
2013
102
0.100
 Why?
Regenerative Medicine
2
2025
12
0.100
 Why?
Organophosphonates
1
2013
7
0.100
 Why?
Testosterone
1
2013
141
0.100
 Why?
Perineum
1
2013
26
0.100
 Why?
DNA, Viral
3
2020
138
0.100
 Why?
Placebos
1
2013
85
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Heart Failure
1
2019
565
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
Piperazines
1
2013
125
0.100
 Why?
tau Proteins
1
2012
25
0.100
 Why?
Prostate
2
2015
116
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
62
0.100
 Why?
Pyrimidines
1
2013
198
0.100
 Why?
Sleep
2
2024
185
0.090
 Why?
Vulvar Neoplasms
1
2013
60
0.090
 Why?
Androgen Antagonists
1
2011
11
0.090
 Why?
Urination Disorders
1
2011
23
0.090
 Why?
Medicare
1
2013
273
0.090
 Why?
Comorbidity
1
2013
628
0.090
 Why?
Sirolimus
1
2012
72
0.090
 Why?
Antibiotics, Antineoplastic
1
2012
79
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
128
0.090
 Why?
Kenya
2
2022
11
0.090
 Why?
Quinazolinones
1
2011
7
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.080
 Why?
Arkansas
1
2016
2016
0.080
 Why?
Practice Guidelines as Topic
1
2013
494
0.080
 Why?
Social Class
1
2011
95
0.080
 Why?
Multivariate Analysis
1
2012
600
0.080
 Why?
Prognosis
5
2017
2093
0.080
 Why?
Chronic Disease
1
2012
585
0.080
 Why?
Piperidines
1
2011
96
0.080
 Why?
Plant Bark
1
2009
4
0.080
 Why?
Multiple Myeloma
2
2014
2999
0.080
 Why?
Valproic Acid
1
2009
35
0.080
 Why?
Ki-67 Antigen
1
2009
58
0.080
 Why?
Socioeconomic Factors
1
2012
603
0.080
 Why?
Colorectal Neoplasms
1
2013
292
0.080
 Why?
Logistic Models
1
2012
925
0.080
 Why?
India
2
2021
58
0.070
 Why?
Fruit
1
2009
129
0.070
 Why?
Tetracyclines
2
2006
9
0.070
 Why?
Neoplasm Recurrence, Local
1
2012
630
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Survival Analysis
3
2017
667
0.070
 Why?
Adaptive Immunity
2
2017
32
0.070
 Why?
Glioblastoma
1
2009
96
0.070
 Why?
Chemoradiotherapy
2
2019
49
0.070
 Why?
Sexual Partners
2
2018
38
0.070
 Why?
Stress, Psychological
1
2009
273
0.070
 Why?
Disease Progression
4
2013
866
0.070
 Why?
Regression Analysis
2
2018
399
0.060
 Why?
Chaperonins
1
2006
3
0.060
 Why?
Chaperonin 60
1
2006
6
0.060
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.060
 Why?
Lymphocyte Count
1
2006
20
0.060
 Why?
Papillomavirus E7 Proteins
1
2006
32
0.060
 Why?
Sexual Behavior
2
2018
125
0.060
 Why?
Immunohistochemistry
3
2017
975
0.060
 Why?
Viral Vaccines
1
2006
16
0.060
 Why?
HIV Protease Inhibitors
1
2006
3
0.060
 Why?
Infant
2
2024
3660
0.060
 Why?
Interferon-alpha
1
2006
52
0.060
 Why?
Nephrosis, Lipoid
1
2005
7
0.060
 Why?
Arterioles
1
2005
32
0.060
 Why?
Brain Neoplasms
1
2009
287
0.060
 Why?
Body Mass Index
2
2022
699
0.060
 Why?
Recombinant Fusion Proteins
1
2006
173
0.060
 Why?
Severity of Illness Index
2
2023
1035
0.060
 Why?
Circadian Clocks
1
2025
3
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
87
0.060
 Why?
Administration, Oral
4
2013
453
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Phenotype
2
2017
794
0.060
 Why?
Anti-Retroviral Agents
2
2019
19
0.060
 Why?
Neutropenia
2
2020
113
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Confidence Intervals
2
2015
159
0.050
 Why?
Dust
1
2024
23
0.050
 Why?
Carbon
1
2024
55
0.050
 Why?
Particulate Matter
1
2024
63
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Bacterial Proteins
1
2006
337
0.050
 Why?
Africa South of the Sahara
1
2022
6
0.050
 Why?
Hip
1
2003
23
0.050
 Why?
Oligomycins
1
2022
8
0.050
 Why?
Rotenone
1
2022
14
0.050
 Why?
Narcotics
1
2023
108
0.050
 Why?
Galactose
1
2022
29
0.050
 Why?
Quality Control
1
2003
98
0.050
 Why?
Sample Size
1
2022
49
0.050
 Why?
Breast Feeding
1
2024
195
0.050
 Why?
Eating
1
2023
159
0.050
 Why?
Femur
1
2003
132
0.050
 Why?
Vitamins
1
2022
65
0.050
 Why?
Spine
1
2003
87
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
9
0.050
 Why?
Glycolysis
1
2022
72
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
253
0.050
 Why?
Vitamin D
1
2022
90
0.050
 Why?
Sodium
1
2022
90
0.050
 Why?
Tretinoin
1
2002
53
0.050
 Why?
Leg
1
2022
121
0.040
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.040
 Why?
Antibodies, Monoclonal
1
2005
475
0.040
 Why?
Museums
1
2021
2
0.040
 Why?
Alprostadil
1
2021
10
0.040
 Why?
Ischemia
1
2022
154
0.040
 Why?
Progesterone
1
2020
58
0.040
 Why?
Oxygen
1
2023
333
0.040
 Why?
Length of Stay
1
2024
666
0.040
 Why?
Kidney
1
2005
713
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Software
1
2003
280
0.040
 Why?
Receptors, Progesterone
1
2020
66
0.040
 Why?
Malawi
1
2020
14
0.040
 Why?
Wharton Jelly
1
2020
2
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Spinal Cord Injuries
1
2020
55
0.040
 Why?
Cell Shape
1
2020
21
0.040
 Why?
Body Composition
1
2003
341
0.040
 Why?
Herpesvirus 4, Human
1
2020
44
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Glucose
1
2022
358
0.040
 Why?
Herpesviridae Infections
1
2020
57
0.040
 Why?
Ceftriaxone
1
2020
24
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
57
0.040
 Why?
B-Lymphocytes
1
2021
180
0.040
 Why?
Drug Resistance, Bacterial
1
2020
76
0.040
 Why?
Thrombocytopenia
1
2020
93
0.040
 Why?
Interleukin-6
2
2016
274
0.040
 Why?
Remission Induction
2
2012
218
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Kaplan-Meier Estimate
1
2020
482
0.040
 Why?
Microbial Sensitivity Tests
1
2020
270
0.040
 Why?
Radiation-Sensitizing Agents
1
2019
50
0.040
 Why?
Forelimb
1
2018
4
0.040
 Why?
Cell Survival
1
2020
596
0.040
 Why?
Green Fluorescent Proteins
1
2018
85
0.040
 Why?
Models, Animal
1
2019
228
0.040
 Why?
Rats, Inbred F344
1
2018
195
0.040
 Why?
Statistics, Nonparametric
2
2013
196
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Cluster Analysis
1
2018
236
0.030
 Why?
Coinfection
1
2018
41
0.030
 Why?
Pandemics
1
2022
579
0.030
 Why?
Bone Marrow
1
2019
361
0.030
 Why?
Neurodegenerative Diseases
1
2019
81
0.030
 Why?
Postural Balance
1
2018
59
0.030
 Why?
Neurogenesis
1
2017
27
0.030
 Why?
Cell Separation
1
2017
73
0.030
 Why?
Muscle Strength
1
2018
131
0.030
 Why?
Cytological Techniques
1
2017
13
0.030
 Why?
Interleukin-2
1
2017
68
0.030
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
92
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.030
 Why?
Staining and Labeling
1
2017
91
0.030
 Why?
Fluorouracil
1
2016
57
0.030
 Why?
Gene Rearrangement
1
2017
76
0.030
 Why?
Biopsy, Needle
1
2017
181
0.030
 Why?
Odds Ratio
1
2018
564
0.030
 Why?
Membrane Glycoproteins
1
2017
238
0.030
 Why?
Interferon-gamma
1
2017
172
0.030
 Why?
Mastectomy
1
2017
144
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
9
0.030
 Why?
Directly Observed Therapy
1
2015
5
0.030
 Why?
Urine
1
2015
25
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Flow Cytometry
1
2017
397
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
RNA, Viral
2
2009
124
0.030
 Why?
Neoadjuvant Therapy
1
2017
123
0.030
 Why?
Treatment Failure
1
2015
122
0.030
 Why?
Prisons
1
2015
39
0.030
 Why?
Ifosfamide
1
2015
9
0.030
 Why?
Cytarabine
1
2015
42
0.030
 Why?
Magnetic Resonance Imaging
1
2022
1518
0.030
 Why?
Methotrexate
1
2015
77
0.030
 Why?
Induction Chemotherapy
1
2014
64
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
33
0.030
 Why?
Depression
1
2019
603
0.030
 Why?
Melphalan
1
2014
178
0.030
 Why?
Cohort Studies
1
2018
1541
0.030
 Why?
Statistics as Topic
1
2013
89
0.030
 Why?
Cancer Care Facilities
1
2013
19
0.030
 Why?
Time
1
2013
29
0.020
 Why?
Administration, Cutaneous
1
2013
53
0.020
 Why?
Gene Expression Regulation
1
2017
1000
0.020
 Why?
Infusions, Intravenous
1
2013
218
0.020
 Why?
Specialization
1
2013
49
0.020
 Why?
Molecular Targeted Therapy
1
2013
132
0.020
 Why?
Demography
1
2013
92
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.020
 Why?
Combined Modality Therapy
1
2014
634
0.020
 Why?
Antitrichomonal Agents
1
2012
1
0.020
 Why?
Risk Assessment
1
2017
1339
0.020
 Why?
Reference Values
1
2013
313
0.020
 Why?
Polyethylene Glycols
1
2012
91
0.020
 Why?
Medical Oncology
1
2013
96
0.020
 Why?
Antigens, Viral
1
2012
43
0.020
 Why?
Administration, Topical
1
2011
60
0.020
 Why?
Single-Blind Method
1
2011
116
0.020
 Why?
Neoplasm Proteins
1
2013
328
0.020
 Why?
Sex Factors
1
2013
731
0.020
 Why?
Organ Size
1
2011
229
0.020
 Why?
Retrospective Studies
1
2022
6610
0.020
 Why?
Antibodies, Viral
1
2010
110
0.020
 Why?
Survival Rate
1
2012
945
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
323
0.020
 Why?
Mutation
1
2013
1318
0.020
 Why?
Psychometrics
1
2009
229
0.020
 Why?
Busulfan
1
2008
17
0.020
 Why?
Mice
1
2017
5877
0.020
 Why?
Ultrasonography
1
2008
420
0.020
 Why?
Maximum Tolerated Dose
1
2006
39
0.020
 Why?
Injections, Subcutaneous
1
2006
51
0.020
 Why?
Hypertension, Renal
1
2005
21
0.010
 Why?
Cell Proliferation
1
2009
1017
0.010
 Why?
Fatigue
1
2006
129
0.010
 Why?
Recombinant Proteins
1
2006
492
0.010
 Why?
Receptors, Interleukin-6
1
2002
23
0.010
 Why?
Endothelial Growth Factors
1
2002
11
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
80
0.010
 Why?
Child, Preschool
1
2005
4001
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (469) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department